Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Pope

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Rheumatic Diseases Clinics of North America|November 1, 1996
Treatment of systemic sclerosisJ E Pope
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Antimitochondrial antibodies and their significance in diffuse and limited sclerodermaJ E Pope, A Thompson
Clinical and Experimental Rheumatology|March 10, 2011
The minimally important difference (MID) for patient-reported outcomes including pain, fatigue, sleep and the health assessment questionnaire disability index (HAQ-DI) in primary Sjögren's syndromeA George, J E Pope
Seminars in Arthritis and Rheumatism|August 1, 1993
Outcome measurement in scleroderma clinical trialsJ E Pope, N Bellamy
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1995
Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trialsJ E Pope, N Bellamy
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
A case of erythema nodosum with arthritisJ E Pope, D McCormack
The Journal of Rheumatology|June 14, 2000
The frequency and significance of anticardiolipin antibodies in sclerodermaJ E Pope, A Thompson
Rheumatology (Oxford, England)|June 26, 2008
Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trialsS Y Yuen, J E Pope
Hospitals|September 16, 1977
Computerized menu printing system reduces clerical tasksJ S Bergaila, J E Pope
Pediatric Dentistry|May 1, 1991
The dental status of cerebral palsied childrenJ E Pope, M E Curzon
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Rheumatic Diseases Clinics of North America|November 1, 1996
Treatment of systemic sclerosisJ E Pope
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Antimitochondrial antibodies and their significance in diffuse and limited sclerodermaJ E Pope, A Thompson
Clinical and Experimental Rheumatology|March 10, 2011
The minimally important difference (MID) for patient-reported outcomes including pain, fatigue, sleep and the health assessment questionnaire disability index (HAQ-DI) in primary Sjögren's syndromeA George, J E Pope
Seminars in Arthritis and Rheumatism|August 1, 1993
Outcome measurement in scleroderma clinical trialsJ E Pope, N Bellamy
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1995
Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trialsJ E Pope, N Bellamy
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
A case of erythema nodosum with arthritisJ E Pope, D McCormack
The Journal of Rheumatology|June 14, 2000
The frequency and significance of anticardiolipin antibodies in sclerodermaJ E Pope, A Thompson
Rheumatology (Oxford, England)|June 26, 2008
Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trialsS Y Yuen, J E Pope
Hospitals|September 16, 1977
Computerized menu printing system reduces clerical tasksJ S Bergaila, J E Pope
Pediatric Dentistry|May 1, 1991
The dental status of cerebral palsied childrenJ E Pope, M E Curzon
Pageof 8